- Filed
- Oct 10, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Oct 4, 2024 | 6.46M sh |
| Long Term Debt | Q1 2024 · Aug 31, 2024 | $144.26K |
| Cash And Equivalents | Q1 2024 · Aug 31, 2024 | $4.15M |
| Cash And Equivalents | Q1 2024 · May 31, 2024 | $3.25M |
| Current Liabilities | Q1 2024 · Aug 31, 2024 | $3.07M |
| Current Liabilities | Q1 2024 · May 31, 2024 | $2.8M |
| Total Liabilities | Q1 2024 · Aug 31, 2024 | $3.47M |
| Total Liabilities | Q1 2024 · May 31, 2024 | $3.28M |
| Current Assets | Q1 2024 · Aug 31, 2024 | $8.34M |
| Current Assets | Q1 2024 · May 31, 2024 | $7.97M |
| Total Assets | Q1 2024 · Aug 31, 2024 | $11.36M |
| Total Assets | Q1 2024 · May 31, 2024 | $10.97M |
| Gross Profit | Q1 2024 · Feb 29, 2024 | $4.15M |
| Gross Profit | Q1 2024 · Aug 31, 2023 | $4.65M |
| Gross Profit | Q1 2024 · Feb 28, 2023 | $4.65M |
| Revenue | Q1 2024 · Feb 29, 2024 | $5.85M |
| Revenue | Q1 2024 · Aug 31, 2023 | $6.11M |
| Revenue | Q1 2024 · Feb 28, 2023 | $6.11M |
| Shares Diluted restated | Q1 2024 · Aug 31, 2023 | 18.62M sh |
| Capex | Q1 2024 · Aug 31, 2023 | $50.96K |
| Operating Cash Flow | Q1 2024 · Aug 31, 2023 | $397.17K |
| Stockholders Equity | Q1 2024 · Aug 31, 2023 | $6.88M |
| Stockholders Equity | Q1 2024 · May 31, 2023 | $6.67M |
| Eps Diluted restated | Q1 2024 · Aug 31, 2023 | $0.01 |
| Eps Basic restated | Q1 2024 · Aug 31, 2023 | $0.03 |
| Sga Expense | Q1 2024 · Aug 31, 2023 | $560.2K |
| Net Income | Q1 2024 · Aug 31, 2023 | $154.45K |
| Operating Income | Q1 2024 · Aug 31, 2023 | $173.76K |